Terumo Cardiovascular Systems' Partner Recognized for Excellence in Neurodiagnostic Technology Development

ANN ARBOR, Mich. — March 25, 2004 — Spencer Technologies, a technology development partner of Terumo Cardiovascular Systems, received the Frost and Sullivan 2004 Medical Devices Excellence in Technology of the Year Award. The award specifically notes achievements in the development of the digital signal processing technology used in Spencer's PDM100 Trans Cranial Doppler (TCD) system. Spencer Technologies and Terumo Cardiovascular Systems are co-developing the next-generation digital TCD device for use during cardiac and vascular surgery.

The PDM100 TCD, the only digital TCD system currently available, uses Power M-Mode Doppler™, a proprietary technology developed by Spencer Technologies. Currently, the system is used to monitor cerebral blood flow and detect emboli during medical procedures. The next generation device will target the reduction of postoperative neurological deficits that may be caused by compromised cerebral flow or embolic insult during surgery.

"Terumo's strength in the development and commercialization of intraoperative monitoring technologies for the cardiac OR is a great compliment for the Spencer technology,” says Kevin Hoffman, General Manager for the CV Monitoring Unit of Terumo Cardiovascular Systems. "Our next generation digital TCD system will bring increased ease-of-use and accuracy to heart teams interested in improving cerebral protection.” Terumo Cardiovascular Systems currently sells a line of blood parameter monitoring equipment and recently launched a myocardial pH monitoring system.


About Terumo Cardiovascular Systems

Terumo Cardiovascular Systems Corporation, a subsidiary of Terumo Corporation of Tokyo, Japan, manufactures, markets, and sells specialty intraoperative monitoring systems and cardiopulmonary bypass products for U.S. and other global cardiac surgery markets. It is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor, as well as Elkton, Maryland; Ashland, Massachusetts; Tustin, California; and Matamoros, Mexico. Terumo Corporation is a premier global medical company with 2002 annual sales in excess of 200 million yen ($1.87 billion). Terumo Corporation develops, manufactures, and markets a wide range of medical products including syringes, needles, catheters, and blood bags. For more information, www.terumo-cvs.com.


About Spencer Technologies

Spencer Technologies was co-founded in 1992 by Dr. Merrill Spencer, a pioneer in the development of diagnostic ultrasound, and Scott Seidel, President and CEO. The company is dedicated to preventing a variety of adverse cardiovascular-related events including strokes, and significantly improving healthcare through the development and use of non-invasive ultrasound technologies for diagnosis, monitoring, and therapeutic effects. Based in Seattle, Washington, Spencer Technologies is involved in all aspects of ultrasound through integrated patient services, clinical research, R&D, manufacturing, and marketing its products and services. The company was ranked among the 2003 Washington State Fast 50 by Deloitte & Touche. For more information, visit www.spencertechnologies.com.